| Chr | chr9 |
| start | 21994778 |
| end | 22121097 |
| lncRNA name | ANRIL |
| entrez id | 100048912 |
| hgnc id | HGNC:34341 |
| ensg id | ENSG00000240498 |
| refseq id | NR_003529 |
| methods | microarray, qPCR etc. |
| regulated | up-regulated |
| function description | Expression level of these 3 lncRNAs was determined in plasma samples of 60 patients with BC and 40 healthy individuals by performing real-time PCR. As expected, the relative expression of ANRIL, HIF1A-AS2, and UCA1 was significantly higher in patients with TNBC than in patients with NTNBC, which was consistent with the results of microarray analysis. |
| pubmed id | 28248879 |
| year | 2017 |
| title | A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers. |
| drug | X |
| circulating | V |
| survival | V |
CopyRight © University of Miami, USA; Harbin Medical University, China